Affiliation:
1. Modibbo Adama University Teaching Hospital
2. American University of Nigeria
3. Johns Hopkins Bloomberg School of Public Health
4. Federal Teaching Hospital
5. Charles Darwin University
6. International Child Health and Social Services Award project (USAID Funded)
7. Johns Hopkins University
Abstract
Abstract
Background
An increased risk of diabetes mellitus (DM) after COVID-19 has been reported in the United States, Europe, and Asia. The burden of COVID-related DM has not been described in Africa, where the overall risk of DM has been increasing rapidly. Our objective was to compare the prevalence of pre-DM and DM in Nigerian individuals with a history of COVID-19 to individuals without known COVID-19 infection.
Methods
We identified 256 individuals with a past medical history of COVID-19 with no history of pre-DM or DM and 256 individuals without a history of COVID-19 or pre-DM/DM. Participants were categorized as pre-DM (fasting capillary glucose 100–125 mg/dL) or DM (fasting capillary glucose ≥ 126 mg/dL). We used multivariate multinomial logistic regression to determine the odds of pre-DM and DM in those with and without a history of COVID-19 after adjustment for age, gender, the presence of hypertension, physical activity, central adiposity, and family history of DM.
Results
Compared to the control group, those with a history of COVID-19 had a similar median age (38 vs 40 years, p = 0.84), had a higher proportion of men (63% vs 49%), and had a lower prevalence of central adiposity (waist: hip ratio ≥ 0.90 for males and WHR ≥ 0.85 for females) (48% vs 56.3%, p = 0.06). Of the 256 with a history of COVID-19, 44 (17%) required inpatient care. The median (interquartile range) time interval between COVID-19 diagnosis and the glycaemic assessment was 19 (14, 24) months. Pre-DM prevalence was 27% in the post-COVID-19 group and 4% in the control group, whereas the prevalence of DM was 7% in the post-COVID-19 group and 2% in the control group. After multivariable adjustment, the odds of pre-DM were 8.12 (95% confidence interval (CI): 33.98, 16.58; p < 0.001) higher, and the odds of DM were 3.97 (95% CI: 1.16, 13.63) higher in those with a history of COVID-19 compared to controls.
Conclusion
Previous COVID-19 was found to be a risk factor for prevalent pre-diabetes and diabetes mellitus in Nigeria. More intensive screening for DM in those with a history of COVID-19 should be considered.
Publisher
Research Square Platform LLC
Reference34 articles.
1. White-Dzuro G, Gibson LE, Zazzeron L, White-Dzuro C, Sullivan Z, Diiorio DA, et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgraduate Medicine. Volume 133. Bellwether Publishing, Ltd.; 2021. pp. 20–7.
2. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis;Zhang T;BMC Med,2022
3. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis;Shrestha DB;World J Virol,2021
4. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis;Zhang T;BMC Med,2022
5. Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews Endocrinology. Volume 17. Nature Research; 2021. pp. 11–30.